Western Europe Australia North America Eastern Europe Middle East Africa Central America South America Asia
Product Description
Jardiance contains the active ingredient Empagliflozin, which belongs to a group of medicines called sodium-glucose cotransporter 2 (SGLT2) inhibitors. Jardiance is a once-daily oral medication that is used to control blood glucose levels in people with type 2 diabetes.